Meda announced new results from its Phase 3 study of Dymista (azelastine HCl and fluticasone propionate; Meda) nasal spray for the treatment of allergic rhinitis. Data from three randomized ...

Data demonstrated that Dymista significantly improved the TNSS compared to placebo and either fluticasone or azelastine alone, during a 14-day treatment period. For more information call (732) 564 ...